STOCK TITAN

Hims & Hers Health Inc Stock Price, News & Analysis

HIMS NYSE

Welcome to our dedicated page for Hims & Hers Health news (Ticker: HIMS), a resource for investors and traders seeking the latest updates and insights on Hims & Hers Health stock.

Hims & Hers Health Inc (HIMS) delivers innovative telehealth solutions through its direct-to-consumer platform, connecting users with licensed professionals for personalized care, wellness products, and prescription services. This news hub provides investors and industry observers with essential updates about the company’s operational milestones and market developments.

Access real-time announcements including quarterly earnings reports, strategic partnerships, product expansions, and regulatory filings. Our curated collection ensures you stay informed about HIMS’ position in the competitive digital healthcare sector without needing to track multiple sources.

Key updates across these areas:

Financial Performance: Earnings calls and SEC filings
Service Innovations: New telehealth offerings and treatment categories
Strategic Growth: Partnerships and market expansion initiatives
Regulatory Compliance: FDA updates and healthcare policy impacts

Bookmark this page for streamlined access to verified HIMS developments. Combine these updates with our analysis tools on Stock Titan to monitor the company’s evolving role in reshaping accessible healthcare solutions.

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.31%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.48%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.82%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.82%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.97%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.56%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.11%
Tags
AI
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.68%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.13%
Tags
Rhea-AI Summary

Hims & Hers Health, Inc. (NYSE: HIMS) is set to report its first quarter 2023 financial results on May 8, 2023, after market close. A live conference call will follow at 5:00 p.m. ET, accessible by U.S. and international participants. In addition, company executives will participate in the Bank of America Merrill Lynch Global Healthcare Conference on May 10, 2023, in Las Vegas. Both events will be available via live audio webcast on the Hims & Hers investor relations website, which will archive these sessions for one year. The platform aims to revolutionize health and wellness by providing personalized care and addressing wellness challenges.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.33%
Tags

FAQ

What is the current stock price of Hims & Hers Health (HIMS)?

The current stock price of Hims & Hers Health (HIMS) is $34.8 as of December 23, 2025.

What is the market cap of Hims & Hers Health (HIMS)?

The market cap of Hims & Hers Health (HIMS) is approximately 8.0B.
Hims & Hers Health Inc

NYSE:HIMS

HIMS Rankings

HIMS Stock Data

7.98B
204.76M
10.63%
88.99%
33.02%
Household & Personal Products
Services-offices & Clinics of Doctors of Medicine
Link
United States
SAN FRANCISCO